Medius Holdings Co., Ltd. (JP:3154)
:3154
Top Page
Medius Holdings Co., Ltd.
(3154)
Select Model
Select Model
Rating:60Neutral
Price Target:
¥855.00
▲(4.65% Upside)
Action:ReiteratedDate:10/29/25
Medius Holdings' overall stock score of 60 is primarily driven by mixed financial performance, with strong cash flow offset by low profitability and high debt levels. Reasonable valuation provides some support, but bearish technical indicators suggest caution due to a downward price trend.
Positive Factors
Revenue Growth
Consistent revenue growth indicates strong market demand and effective sales strategies, enhancing long-term business sustainability.
Negative Factors
Increased Leverage
Higher leverage can increase financial risk and limit flexibility, potentially impacting the company's ability to invest in growth opportunities.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
Consistent revenue growth indicates strong market demand and effective sales strategies, enhancing long-term business sustainability.
Read all positive factors
Medius Holdings Co., Ltd. (3154) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥18.63B
Dividend Yield2.46%
Average Volume (3M)18.80K
Price to Earnings (P/E)16.3
Beta (1Y)0.62
Revenue Growth8.52%
EPS Growth25.85%
CountryJP
Employees2,517
SectorHealthcare
Sector Strength45
IndustryMedical - Instruments & Supplies
Share Statistics
EPS (TTM)N/A
Shares Outstanding22,238,216
10 Day Avg. Volume22,330
30 Day Avg. Volume18,803
Financial Highlights & Ratios
PEG Ratio0.66
Price to Book (P/B)0.95
Price to Sales (P/S)0.07
P/FCF Ratio3.71
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Medius Holdings Co., Ltd. Business Overview & Revenue Model
Company Description
Medius Holdings Co., Ltd. operates in the medical care industry in Japan. The company sells medical equipment, such as syringes, gauze, other necessary medical consumables, and advanced medical system; and provides repair, after-sales, and mainten...
How the Company Makes Money
Medius Holdings generates revenue through a combination of software licensing, subscription services, and consulting fees associated with its healthcare technology solutions. The company typically charges clients for initial software licenses, fol...
Medius Holdings Co., Ltd. Financial Statement Overview
Summary
Income Statement
65
Positive
Balance Sheet
55
Neutral
Cash Flow
75
Positive
| Breakdown | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 288.69B | 259.79B | 239.05B | 221.69B | 246.79B |
| Gross Profit | 33.30B | 31.09B | 29.31B | 27.42B | 25.20B |
| EBITDA | 4.77B | 3.86B | 4.27B | 3.80B | 4.14B |
| Net Income | 1.38B | 1.12B | 1.50B | 1.87B | 2.07B |
Balance Sheet | |||||
| Total Assets | 113.54B | 115.34B | 97.73B | 93.15B | 84.68B |
| Cash, Cash Equivalents and Short-Term Investments | 14.33B | 13.64B | 10.33B | 9.11B | 12.62B |
| Total Debt | 21.89B | 24.57B | 19.70B | 17.98B | 11.83B |
| Total Liabilities | 93.06B | 95.60B | 79.15B | 75.84B | 68.84B |
| Stockholders Equity | 20.48B | 19.74B | 18.57B | 17.31B | 15.84B |
Cash Flow | |||||
| Free Cash Flow | 5.26B | 261.12M | 300.65M | -8.49B | 2.93B |
| Operating Cash Flow | 7.01B | 1.92B | 1.22B | -3.90B | 6.85B |
| Investing Cash Flow | -2.51B | -2.67B | -862.94M | -4.82B | -4.62B |
| Financing Cash Flow | -3.47B | 4.01B | 862.90M | 5.21B | 1.90B |
Medius Holdings Co., Ltd. Technical Analysis
Positive
817.00
Price Trends
815.66
Positive
814.71
Positive
834.71
Positive
Market Momentum
10.52
Negative
57.83
Neutral
83.57
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3154, the sentiment is Positive. The current price of 817 is above the 20-day moving average (MA) of 813.20, above the 50-day MA of 815.66, and below the 200-day MA of 834.71, indicating a bullish trend. The MACD of 10.52 indicates Negative momentum. The RSI at 57.83 is Neutral, neither overbought nor oversold. The STOCH value of 83.57 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:3154.
Medius Holdings Co., Ltd. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ¥152.21B | 18.72 | ― | 2.73% | 5.10% | -26.13% | |
68 Neutral | ¥954.90B | 24.33 | 11.64% | 0.82% | 13.53% | -7.39% | |
67 Neutral | ¥62.95B | 19.92 | ― | 2.83% | 3.69% | 1.86% | |
63 Neutral | ¥241.17B | -69.02 | -2.06% | 2.66% | 5.43% | -20.67% | |
60 Neutral | ¥18.63B | 16.30 | ― | 2.46% | 8.52% | 25.85% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
46 Neutral | ¥10.58B | 31.52 | ― | 3.85% | 0.38% | ― |
* Healthcare Sector Average
JP:3154
Medius Holdings Co., Ltd.
838.00
-53.41
-5.99%
JP:7747
Asahi Intecc Co
3,599.00
1,343.25
59.55%
JP:7716
Nakanishi
2,857.00
1,044.77
57.65%
JP:7702
JMS Co., Ltd.
433.00
16.19
3.88%
JP:7730
Mani, Inc.
1,545.00
458.22
42.16%
JP:7979
Shofu Inc.
1,764.00
-249.93
-12.41%
Medius Holdings Co., Ltd. Corporate Events
Medius Holdings Reports Strong Q1 Performance with Strategic Expansion
Nov 11, 2025
Medius Holdings Co., Ltd. reported a 4.4% increase in net sales and a significant 47.1% rise in profit attributable to owners for the first quarter ended September 30, 2025. Despite these positive results, the company experienced a decrease in its...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.